SCHEMBL1405552

SCHEMBL1405552

CN(C)c1ccc(C=Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.70
ALDH1A1 P00352 8/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
MAPK1 P28482 3/20 0.70
LMNA P02545 3/20 0.70
HPGD P15428 2/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
NPC1 O15118 1/20 0.70
RAB9A P51151 1/20 0.70
TDP1 Q9NUW8 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HCAR3 P49019 1/20 0.54
KDM4E B2RXH2 3/20 0.52
POLB P06746 1/20 0.52
KMT2A Q03164 1/20 0.52
NFE2L2 Q16236 2/20 0.51
GLA P06280 1/20 0.51
HTT P42858 1/20 0.50
ALDH3A1 P30838 2/20 0.48
CYP19A1 P11511 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405551 1.00 MAPT (0.70) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL8297702 0.83 MAPT (0.60) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL6496805 0.82 MAPT (0.74) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL6496803 0.82 MAPT (0.74) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL7142928 0.81 ALDH3A1 (0.69) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL29403345 0.81 ALDH3A1 (0.69) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL9798323 0.80 MAPT (0.53) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL811420 0.80 NFE2L2 (0.56) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL811421 0.80 NFE2L2 (0.56) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL4309326 0.76 VCAM1 (0.65) MAPTALDH1A1MAPK1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021074275-A1 EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE UNIVERSITE DE RENNES 1 (FR) 2021-04-22 WO disclosed
US-9868873-B2 Photochromic security enabled ink for digital offset printing applications XEROX CORPORATION (US) 2018-01-16 US disclosed
US-20130305947-A1 PHOTOCHROMIC SECURITY ENABLED INK FOR DIGITAL OFFSET PRINTING APPLICATIONS XEROX CORPORATION (US) 2013-11-21 US disclosed
EP-1591830-B1 Reimageable medium XEROX CORP (US) 2011-03-09 EP disclosed
US-7556844-B2 Radiation curable photochromic inks XEROX CORPORATION (US) 2009-07-07 US disclosed
US-7521159-B2 Multicolor electronic paper XEROX CORPORATION (US) 2009-04-21 US disclosed
US-7300727-B2 Method for forming temporary image XEROX CORPORATION (US) 2007-11-27 US disclosed
US-20070211110-A1 RADIATION CURABLE PHOTOCHROMIC INKS XEROX CORPORATION (US) 2007-09-13 US disclosed
US-7214456-B2 Reimageable medium XEROX CORPORATION (US) 2007-05-08 US disclosed
US-7205088-B2 Reimageable medium with light absorbing material XEROX CORPORATION (US) 2007-04-17 US disclosed
US-20050244743-A1 Reimageable medium XEROX CORPORATION. 2005-11-03 US disclosed
US-20050244742-A1 Reimageable medium with light absorbing material XEROX CORPORATION 2005-11-03 US disclosed
US-20050244744-A1 Method for forming temporary image XEROX CORPORATION 2005-11-03 US disclosed
EP-1591830-A2 Reimageable medium Xerox Corporation (US) 2005-11-02 EP disclosed
EP-1591831-A2 Reimageable medium with light absorbing material Xerox Corporation (US) 2005-11-02 EP disclosed
EP-1591829-A1 Method for forming temporary image Xerox Corporation (US) 2005-11-02 EP disclosed
US-5759729-A A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY XEROX CORPORATION (US) 1998-06-02 US disclosed
US-5710420-A Method for embedding and recovering machine-readable information XEROX CORPORATION (US) 1998-01-20 US disclosed
US-5593486-A Photochromic hot melt ink compositions XEROX CORPORATION (US) 1997-01-14 US disclosed
US-5551973-A LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE XEROX CORPORATION (US) 1996-09-03 US disclosed